Access Bio, Inc. (KOSDAQ:950130)

Access Bio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	356,613	342,245	277,607	473,199	199,083	49,211
Short-Term Investments	21,108	50,105	11,198	13,879	1,250	1,138
Trading Asset Securities	63,190	62,497	58,171	11,636	-	-
Cash & Short-Term Investments	440,912	454,847	346,976	498,714	200,333	50,348
Cash Growth	18.76%	31.09%	-30.43%	148.94%	297.89%	516.25%
Accounts Receivable	6,311	7,633	17,783	91,221	54,643	27,480
Other Receivables	1,519	1,604	3,879	1,084	1,081	934.47
Receivables	8,740	10,147	22,046	92,322	56,379	28,493
Inventory	18,852	23,460	32,224	114,170	54,477	27,967
Prepaid Expenses	433.74	599.13	790.42	1,251	869.97	589.52
Other Current Assets	12,654	11,190	16,396	9,287	16,132	4,547
Total Current Assets	481,591	500,243	418,433	715,744	328,190	111,945
Property, Plant & Equipment	132,043	137,180	139,506	130,547	80,586	49,125
Long-Term Investments	63,968	61,673	100,981	4,000	0	-
Other Intangible Assets	224.82	237.86	386.73	445.95	522.29	600
Long-Term Deferred Tax Assets	34,106	32,599	25,819	27,989	24,139	1,920
Long-Term Deferred Charges	359.22	395.72	816.28	1,025	1,196	1,341
Other Long-Term Assets	6,778	8,150	4,705	5,723	7,361	4,671
Total Assets	719,442	740,851	691,136	885,480	442,009	170,184
Accounts Payable	606.21	1,151	3,459	2,196	9,737	4,728
Accrued Expenses	4,835	13,879	14,375	156,874	22,221	262.65
Short-Term Debt	-	-	8,963	8,884	56,142	33,352
Current Portion of Long-Term Debt	14,660	14,690	120	120	-	166.66
Current Portion of Leases	7,422	5,404	4,344	3,975	1,932	1,319
Current Income Taxes Payable	239.05	502.78	-	8,647	14,668	11,185
Current Unearned Revenue	-	49.81	99.32	-	-	-
Other Current Liabilities	1,508	4,727	12,658	15,609	33,551	18,624
Total Current Liabilities	29,271	40,403	44,017	196,304	138,250	69,638
Long-Term Debt	-	-	14,690	14,810	-	152.77
Long-Term Leases	41,827	45,906	45,024	47,632	12,008	12,278
Long-Term Unearned Revenue	-	-	-	635.8	594.76	435.2
Long-Term Deferred Tax Liabilities	2,856	2,137	264.05	-	-	-
Other Long-Term Liabilities	-	-	-	0	1,110	1,000
Total Liabilities	73,954	88,446	103,995	259,382	151,962	83,503
Common Stock	2,786	2,792	2,362	2,318	2,168	1,990
Additional Paid-In Capital	72,599	72,773	54,217	65,704	61,451	56,304
Retained Earnings	638,962	647,142	567,965	590,149	233,950	34,371
Treasury Stock	-40,812	-40,909	-35,883	-32,943	-4,570	-4,194
Comprehensive Income & Other	-30,091	-31,646	-4,504	-7,115	-6,409	-4,750
Total Common Equity	643,444	650,152	584,155	618,112	286,590	83,721
Minority Interest	2,043	2,253	2,986	7,986	3,457	2,960
Shareholders' Equity	645,488	652,405	587,141	626,098	290,047	86,681
Total Liabilities & Equity	719,442	740,851	691,136	885,480	442,009	170,184
Total Debt	63,909	66,000	73,141	75,421	70,081	47,268
Net Cash (Debt)	377,003	388,847	273,835	423,293	130,251	3,080
Net Cash Growth	26.91%	42.00%	-35.31%	224.98%	4128.83%	-
Net Cash Per Share	10898.73	11352.88	8105.08	11183.97	3491.51	88.96
Filing Date Shares Outstanding	35.17	35.17	33.81	33.96	35.6	35.6
Total Common Shares Outstanding	35.17	35.17	33.81	33.96	35.6	35.6
Working Capital	452,320	459,840	374,416	519,440	189,940	42,308
Book Value Per Share	18293.27	18483.97	17276.64	18199.04	8049.82	2351.59
Tangible Book Value	643,220	649,914	583,768	617,666	286,067	83,121
Tangible Book Value Per Share	18286.88	18477.21	17265.20	18185.91	8035.15	2334.73
Land	4,285	4,285	4,285	4,285	4,161	4,107
Buildings	14,808	14,808	14,807	12,402	12,302	12,324
Machinery	89,505	89,715	76,949	48,906	25,801	16,487
Construction In Progress	4,955	4,155	6,696	28,746	32,495	6,538

Source: S&P Global Market Intelligence. Standard template. Financial Sources.